CD8+ T-cell interleukin-7 receptor alpha expression as a potential indicator of disease status in HIV-infected children

PLoS ONE

Volumn 3, Issue 12, 2008, Pages

  Sharma, Tanvi S ^a   Hughes, Jane ^b   Murillo, Amarylis ^c   Riley, Joanne ^b   Soares, Andrela ^b   Little, Francesca ^d   Mitchell, Charles D ^c   Hanekom, Willem A ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD38 ANTIGEN; INTERLEUKIN 7 RECEPTOR; INTERLEUKIN 7 RECEPTOR ALPHA; BIOLOGICAL MARKER;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN EXPRESSION; ARTICLE; BLOOD ANALYSIS; BODY HEIGHT; BODY WEIGHT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL PRACTICE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE MARKER; FEMALE; FLOW CYTOMETRY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PROTEIN DETERMINATION; SCHOOL CHILD; T LYMPHOCYTE SUBPOPULATION; VIRUS LOAD; CHILD; CROSS-SECTIONAL STUDY; HEALTH SURVEY; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; METABOLISM; PATHOLOGY; PROGNOSIS;

BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; HEALTH STATUS INDICATORS; HIV INFECTIONS; HIV-1; HUMANS; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE COUNT; MALE; PROGNOSIS; VIRAL LOAD;

EID: 58049196876     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003986     Document Type: Article

References (39)

1. Essajee SM, Kim M, Gonzalez C, Rigaud M, Kaul A, et al. (1999) Immunologic and virologic responses to HAART in severely immunocompromised HIV-1-infected children. Acquir Immune Defic Syndr 13: 2523-2532.
2. Bohler T, Walcher J, Holzl-Wenig G, Geiss M, Buchholz B, et al. (1999) Early effects of antiretroviral combination therapy on activation, apoptosis and regeneration of T cells in HIV-1-infected children and adolescents. Acquir Immune Defic Syndr 13: 779-789.
3. Resino S, Galan I, Perez A, Leon JA, Seoane E, et al. (2004) HIV-infected children with moderate/severe immune-suppression: changes in the immune system after highly active antiretroviral therapy. Clin Exp Immunol 137: 570-577.
4. Harari A, Petitpierre S, Vallelian F, Pantaleo G (2004) Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy. Blood 103: 966-972.
5. Borkowsky W, Stanley K, Douglas SD, Lee S, Wiznia A, et al. (2000) Immunologic response to combination nucleoside analogue plus protease inhibitor therapy in stable antiretroviral therapy-experienced human immunodeficiency virus-infected children. J Infect Dis 182: 96-103.
6. Rosenblatt HM, Stanley KE, Song LY, Johnson GM, Wiznia AA, et al. (2005) Immunological response to highly active antiretroviral therapy in children with clinically stable HIV-1 infection. J Infect Dis 192: 445-455.
7. Colle JH, Moreau JL, Fontanet A, Lambotte O, Joussemet M, et al. (2006) CD127 expression and regulation are altered in the memory CD8 T cells of HIV-infected patients-reversal by highly active anti-retroviral therapy (HAART). Clin Exp Immunol 143: 398-403.
8. Koesters SA, Alimonti JB, Wachihi C, Matu L, Anzala O, et al. (2006) IL-7R alpha expression on CD4+ T lymphocytes decreases with HIV disease progression and inversely correlates with immune activation. Eur J Immunol 36: 336-344.
9. MacPherson PA, Fex C, Sanchez-Dardon J, Hawley-Foss N, Angel JB (2001) Interleukin-7 receptor expression on CD8(+) T cells is reduced in HIV infection and partially restored with effective antiretroviral therapy. J Acquir Immune Defic Syndr 28: 454-457.
10. Mussini C, Pinti M, Borghi V, Nasi M, Amorico G, et al. (2002) Features of 'CD4-exploders', HIV-positive patients with an optimal immune reconstitution after potent antiretroviral therapy. Acquir Immune Defic Syndr 16: 1609-1616.
11. Paiardini M, Cervasi B, Albrecht H, Muthukumar A, Dunham R, et al. (2005) Loss of CD127 expression defines an expansion of effector CD8+ T cells in HIV-infected individuals. J Immunol 174: 2900-2909.
12. Read SW, Higgins J, Metcalf JA, Stevens RA, Rupert A, et al. (2006) Decreased CD127 expression on T Cells in HIV-1-infected adults receiving antiretroviral therapy with or without intermittent IL-2 therapy. J Acquir Immune Defic Syndr 42: 537-544.
13. Rethi B, Fluur C, Atlas A, Krzyzowska M, Mowafi F, et al. (2005) Loss of IL-7Ralpha is associated with CD4 T-cell depletion, high interleukin-7 levels and CD28 down-regulation in HIV infected patients. Acquir Immune Defic Syndr 19: 2077-2086.
14. Sasson SC, Zaunders JJ, Zanetti G, King EM, Merlin KM, et al. (2006) Increased plasma interleukin-7 level correlates with decreased CD127 and Increased CD132 extracellular expression on T cell subsets in patients with HIV-1 infection. J Infect Dis 193: 505-514.
15. Wherry EJ, Day CL, Draenert R, Miller JD, Kiepiela P, et al. (2006) HIV-specific CD8 T cells express low levels of IL-7Ralpha: Implications for HIV-specific T cell memory. Virology 353(2): 366-73.
16. Alpdogan O, van den Brink MR (2005) IL-7 and IL-15: therapeutic cytokines for immunodeficiency. Trends Immunol 26: 56-64.
17. Bradley LM, Haynes L, Swain SL (2005) IL-7: maintaining T-cell memory and achieving homeostasis. Trends Immunol 26: 172-176.
18. Fry TJ, Mackall CL (2005) The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. J Immunol 174: 6571-6576.
19. Beq S, Bugault F, Colle JH, Lambotte O, Delfraissy JF, et al. (2005) Antiretroviral therapy in HIV-infected patients: in vitro effects of AZT and saquinavir on the response of CD4 and CD8 lymphocytes to interleukin-7. Eur Cytokine Netw 16: 293-299.
20. Chiappini E, Galli L, Azzari C, de Martino M (2003) Interleukin-7 and immunologic failure despite treatment with highly active antiretroviral therapy in children perinatally infected with HIV-1. J Acquir Immune Defic Syndr 33: 601-604.
21. Resino S, Galan I, Correa R, Pajuelo L, Bellon JM, et al. (2005) Homeostatic role of IL-7 in HIV-1 infected children on HAART: association with immunological and virological parameters. Acta Paediatr 94: 170-177.
22. Colle JH, Moreau JL, Fontanet A, Lambotte O, Joussemet M, et al. (2006) Regulatory dysfunction of the interleukin-7 receptor in CD4 and CD8 lymphocytes from HIV-infected patients-effects of antiretroviral therapy. J Acquir Immune Defic Syndr 42: 277-285.
23. Pahwa R, McCloskey TW, Aroniadis OC, Strbo N, Krishnan S, et al. (2006) CD8+ T cells in HIV disease exhibit cytokine receptor perturbation and poor T cell receptor activation but are responsive to gamma-chain cytokine-driven proliferation. J Infect Dis 193: 879-887.
24. Vigano A, Saresella M, Villa ML, Ferrante P, Clerici M (2000) CD38+CD8+ T cells as a marker of poor response to therapy in HIV-infected individuals. Chem Immunol 75: 207-217.
25. Arpadi SM (2000) Growth failure in children with HIV infection. J Acquir Immune Defic Syndr 25 (Suppl 1): S37-42.
26. Verweel G, van Rossum AM, Hartwig NG, Wolfs TF, Scherpbier HJ, et al. (2002) Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth. Pediatrics 109: E25.
27. Schlesinger M, Peters V, Jiang JD, Roboz JP, Bekesi JG (1995) Increased expression of activation markers on CD8 lymphocytes in children with human immunodeficiency virus-1 infection. Pediatr Res 38: 390-396.
28. Mocroft A, Bofill M, Lipman M, Medina E, Borthwick N, et al. (1997) CD8+, CD38+ lymphocyte percent: a useful immunological marker for monitoring HIV-1-infected patients. J Acquir Immune Defic Syndr Hum Retrovirol 14: 158-162.
29. Dunham RM, Cervasi B, Brenchley JM, Albrecht H, Weintrob A, et al. (2008) CD127 and CD25 expression defines CD4+ T cell subsets that are differentially depleted during HIV infection. J Immunol 180(8): 5582-92.
30. Mercier F, Boulassel MR, Yassine-Diab B, Tremblay C, Bernard NF, et al. (2008) Persistent human immunodeficiency virus-1 antigenemia affects the expression of interleukin-7R alpha on central and effector memory CD4+ and CD8+ T cell subsets. Clin Exp Immunol 152(1): 72-80.
31. Romero P, Zippelius A, Kurth I, Pittet MJ, Touvrey C, et al. (2007) Four functionally distinct populations of human effector-memory CD8+ T lymphocytes. J Immunol 178(7): 4112-9.
32. Boettler T, Panther E, Bengsch B, Nazarova N, Spangenberg HC, et al. (2006) Expression of the interleukin-7 receptor alpha chain (CD127) on virus-specific CD8+ T cells identifies functionally and phenotypically defined memory T cells during acute resolving hepatitis B virus infection. J Virol 80(7): 3532-40.
33. Golden-Mason L, Burton JR Jr, Castelblanco N, Klarquist J, Benlloch S, et al. (2006) Loss of IL-7 receptor alpha-chain (CD127) expression in acute HCV infection associated with viral persistence. Hepatology 44(5): 1098-109.
34. Marrack P, Kappler J (2004) Control of T cell viability. Annu Rev Immunol 22: 765-787.
35. Nunnari G, Pomerantz RJ (2005) IL-7 as a potential therapy for HIV-1-infected individuals. Expert Opin Biol Ther 5: 1421-1426.
36. Pett SL, Kelleher AD (2003) Cytokine therapies in HIV-1 infection: present and future. Expert Rev Anti Infect Ther 1: 83-96.
37. Ahmad A, Ahmad R, Iannello A, Toma E, Morisset R, et al. (2005) IL-15 and HIV infection: lessons for immunotherapy and vaccination. Curr HIV Res 3: 261-270.
38. Sportès C, Hakim FT, Memon SA, Zhang H, Chua KS, et al. (2008) Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. J Exp Med 205: 1701-1714.
39. CDC (1994) Revised classification for human immunodeficiency virus infection in children less than 13 years old. MMWR 43: 1-10.